ARCUTIS BIOTHERAPEUTICS INC filings

SEC filings by ARCUTIS BIOTHERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13D/A2024-03-06Frazier Life Sciences VIII, L.P.Arcutis Biotherapeutics, Inc.8,785,2847.8%EDGAR
SC 13G/A2024-03-06JENNISON ASSOCIATES LLCArcutis Biotherapeutics, Inc.12,128,53310.8%EDGAR
SC 13G/A2024-02-14PRUDENTIAL FINANCIAL INCArcutis Biotherapeutics, Inc.9,884,13710.5%EDGAR
SC 13G/A2024-02-13SUVRETTA CAPITAL MANAGEMENT, LLCArcutis Biotherapeutics, Inc.9,534,83710.0%EDGAR
SC 13G/A2024-02-13Polar Capital Holdings PlcArcutis Biotherapeutics, Inc.6,297,6886.7%EDGAR
SC 13G2024-02-13VANGUARD GROUP INCArcutis Biotherapeutics, Inc.4,896,5135.2%EDGAR
SC 13G2024-02-12MORGAN STANLEYArcutis Biotherapeutics, Inc.6,093,4976.5%EDGAR
SC 13G2024-02-12Rubric Capital Management LPArcutis Biotherapeutics, Inc.6,644,5307.0%EDGAR
SC 13G2024-02-08JENNISON ASSOCIATES LLCArcutis Biotherapeutics, Inc.9,066,0829.6%EDGAR
SC 13G2024-01-31Point72 Asset Management, L.P.Arcutis Biotherapeutics, Inc.4,836,1165.1%EDGAR
SC 13G2024-01-29BlackRock Inc.Arcutis Biotherapeutics, Inc.5,916,5466.3%EDGAR
SC 13G/A2024-01-23STATE STREET CORPArcutis Biotherapeutics, Inc.-1.6%EDGAR
SC 13G2023-11-16Polar Capital Holdings PlcArcutis Biotherapeutics, Inc.7,117,9447.6%EDGAR
SC 13G/A2023-11-13FMR LLCArcutis Biotherapeutics, Inc.3,551,2613.8%EDGAR
SC 13G2023-11-09PRUDENTIAL FINANCIAL INCArcutis Biotherapeutics, Inc.9,650,81110.2%EDGAR
SC 13G/A2023-11-07BlackRock Inc.Arcutis Biotherapeutics, Inc.3,880,4024.1%EDGAR
SC 13G2023-10-30SUVRETTA CAPITAL MANAGEMENT, LLCArcutis Biotherapeutics, Inc.9,592,21210.0%EDGAR
SC 13D/A2023-10-26Frazier Life Sciences VIII, L.P.Arcutis Biotherapeutics, Inc.8,764,2329.3%EDGAR
SC 13G/A2023-02-14Point72 Asset Management, L.P.Arcutis Biotherapeutics, Inc.1,103,5761.8%EDGAR
SC 13G/A2023-02-09FMR LLCArcutis Biotherapeutics, Inc.9,139,17315.0%EDGAR